세계의 일회용 바이오프로세싱 시장 보고서(2025년)
Single Use Bioprocessing Global Market Report 2025
상품코드 : 1821601
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

일회용 바이오프로세싱 시장의 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 20.8%로 680억 4,000만 달러로 성장할 전망입니다. 예측기간의 성장은 맞춤형 의료, 유전자 및 세포 치료 생산, 연속 바이오프로세스 도입, 희귀질환용 바이오 제조, 바이오 세이프티 레벨의 확대, 신흥 시장, 세계적 바이오 제조 허브 등의 확대에 기인할 것으로 예측됩니다. 예측기간의 주요 동향에는 자동화 및 로봇화 일회용 시스템, 일회용 센서 및 분석, 폐쇄 시스템의 무균 충전 및 포장, 모듈식 및 확장 가능한 바이오프로세싱 시설, 온디맨드 및 분산형 바이오 제조, 바이러스 여과 및 정제 솔루션이 포함됩니다.

향후 5년간의 예측 성장률 20.8%는 과거 예측에서 0.2% 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 아일랜드와 덴마크에서 조달하는 일회용 바이오리액터와 여과 어셈블리의 비용을 증가시켜 생물학적 제제의 제조 비용을 악화시키고 백신의 확장성을 제한함으로써 미국의 바이오 제조업에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 늘어날 것으로 보입니다.

바이오 의약품에 대한 수요 증가는 일회용 바이오프로세싱 시장의 향후 성장을 이끌 것으로 예측됩니다. 바이오 의약품은 살아있는 세포와 생물에서 유래한 의약품입니다. 일회용 바이오프로세싱 시스템은 생산성 향상, 비용 절감, 폐기물의 안전한 처리를 위해 바이오 의약품 제조에 널리 채택되고 있습니다. 예를 들어 2023년 6월 벨기에에 본부를 둔 제약 부문 대표 단체 유럽제약단체연합회(EFPIA)는 유럽 제약업계의 현저한 성장을 보고하였으며 생산액은 2021년 3,524억 8,000만 달러에서 2022년에는 3,699억에 달한 것으로 나타났습니다. 따라서 바이오 의약품에 대한 수요 증가가 일회용 바이오프로세싱 시장의 확대를 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Single-use bioprocessing refers to the use of bioprocessing equipment designed for one-time use and subsequent disposal. These products are typically constructed from plastic components that undergo sterilization through gamma radiation. Single-use bioprocessing offers advantages such as saving time spent on cleaning, reducing water usage, and lowering energy consumption. This approach is applied across the bioproduction workflow to minimize the risk of cross-contamination.

The primary product types in the single-use bioprocessing market include single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and other related products. Single-use media bags and containers serve the purpose of containing sterile media, cell cultures, sera, buffers, and reagents. These containers are designed for one-time use and subsequent disposal. The workflows in which single-use bioprocessing is employed include upstream, fermentation, and downstream processes. Various applications of single-use bioprocessing include filtration, storage, cell culture, mixing, and purification. This approach is adopted by biopharmaceutical and pharmaceutical companies, contract research organizations, contract manufacturing organizations (CROs and CMOs), as well as academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The single-use bioprocessing market research report is one of a series of new reports from The Business Research Company that provides single-use bioprocessing market statistics, including single-use bioprocessing industry global market size, regional shares, competitors with a single-use bioprocessing market share, detailed single-use bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bioprocessing industry. This single-use bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single use bioprocessing market size has grown rapidly in recent years. It will grow from $26.87 billion in 2024 to $31.94 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to biopharmaceutical production, biotechnology and cell culture processes, reduction of cross-contamination risks, regulatory compliance in bioprocessing, and demand for cost-effective solutions.

The single use bioprocessing market size is expected to see exponential growth in the next few years. It will grow to $68.04 billion in 2029 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to expansion of personalized medicine, gene and cellTherapy production, continuous bioprocessing adoption, biomanufacturing for rare diseases, expansion of biosafety levels, emerging markets and global biomanufacturing hubs. Major trends in the forecast period include automated and robotic single-use systems, single-use sensors and analytics, closed-system aseptic filling and packaging, modular and scalable bioprocessing facilities, on-demand and decentralized biomanufacturing, virus filtration and purification solutions.

The forecast of 20.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. biomanufacturing by driving up the cost of disposable bioreactors and filtration assemblies sourced from Ireland and Denmark, exacerbating biologic drug production costs and limiting vaccine scalability. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising demand for biopharmaceuticals is anticipated to drive the growth of the single-use bioprocessing market in the future. Biopharmaceuticals are medicines derived from living cells or organisms. Single-use bioprocessing systems are widely employed in biopharmaceutical manufacturing to enhance productivity, reduce costs, and ensure the safe disposal of waste. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based organization representing the pharmaceutical sector, reported significant growth in the European pharmaceutical industry, with production increasing from $352.48 billion in 2021 to $369.95 billion in 2022. Therefore, the growing demand for biopharmaceuticals is propelling the expansion of the single-use bioprocessing market.

The escalation of chronic diseases is poised to be a significant factor propelling the growth of the single-use bioprocessing market. Chronic diseases, characterized by prolonged medical conditions lasting three months or more, necessitate ongoing treatment. Single-use bioprocessing technologies are instrumental in the manufacturing of biopharmaceuticals used to combat chronic diseases such as diabetes, cancer, and autoimmune disorders. The prevalence of chronic illnesses is expected to rise by 99.5%, reaching 142.66 million individuals aged 50 years and older by 2050 in the United States, as reported by the National Library of Medicine. This demographic shift towards chronic diseases is expected to contribute substantially to the expansion of the single-use bioprocessing market.

A noteworthy trend in the single-use bioprocessing market involves technological advancements that major industry players are adopting to maintain a competitive edge. For example, Cytiva, a U.S.-based company, introduced X-platform bioreactors designed to enhance efficiency in single-use upstream bioprocessing. These bioreactors, ranging in size from 50 to 200 liters, come equipped with the Figurate automation solution software, improving process efficiency, increasing production capacity, and streamlining supply chain operations.

Innovation is a key focus for major companies in the single-use bioprocessing market, exemplified by products like Ultimus Single-Use Process Container Film. This innovation, integrated into Merck Group's Mobius 3D process containers, provides exceptional durability and leak resistance for single-use assemblies in bioprocessing liquid applications. The film features a unique woven nylon structure, offering enhanced bag strength and improved resilience to issues like abrasions, tears, and material fatigue.

For example, in May 2024, Novo Holdings A/S, a Denmark-based investment company, acquired a 60% majority stake in Single Use Support GmbH for an undisclosed sum. This acquisition enables Novo Holdings to enhance its manufacturing capabilities and supply chain, particularly in support of its pharmaceutical subsidiary. Single Use Support GmbH is an Austria-based company that specializes in providing single-use bioprocessing products for the life sciences sector.

Major companies operating in the single use bioprocessing market include GE Healthcare Technologies Ltd., Eppendorf AG, Corning Incorporated, Thermo Fisher Scientific Inc., Sartorius AG, JM BioConnect BV, Merck KGaA, Pall Corporation, Kuhner AG, PBS Biotech Inc., Entegris Inc., DistriCell Inc., ABEC Inc., Able Corporation and Biott Corporation, Solida Biotech GmbH, OmniBRx Biotechnologies Pvt. Ltd., Satake Chemical Equipment Mfg. Co. Ltd., Stobbe Pharma GmbH, Celltainer Biotech BV, Cellexus BV, Danaher Corporation, Boehringer Ingelheim International GmbH, General Electric Company, Rentschler Biopharma SE, Repligen Corporation, Sollesis Medical Plc, Charter Medical Inc., Secant Group LLC, Lonza Group Ltd., Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Pfizer Inc., Catalent Inc., Patheon Inc., Bio-Rad Laboratories Inc., Avantor Performance Materials India Limited, MilliporeSigma, Saint-Gobain Performance Plastics Corp., Meissner Filtration Products Inc.

North America was the largest region in the single-use bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single use bioprocessing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the single use bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The single-use bioprocessing market includes revenues earned by entities by bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags and containers, mixing systems, tubing assemblies and sampling systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single Use Bioprocessing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single use bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for single use bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single use bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Single Use Bioprocessing Market Characteristics

3. Single Use Bioprocessing Market Trends And Strategies

4. Single Use Bioprocessing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Single Use Bioprocessing Growth Analysis And Strategic Analysis Framework

6. Single Use Bioprocessing Market Segmentation

7. Single Use Bioprocessing Market Regional And Country Analysis

8. Asia-Pacific Single Use Bioprocessing Market

9. China Single Use Bioprocessing Market

10. India Single Use Bioprocessing Market

11. Japan Single Use Bioprocessing Market

12. Australia Single Use Bioprocessing Market

13. Indonesia Single Use Bioprocessing Market

14. South Korea Single Use Bioprocessing Market

15. Western Europe Single Use Bioprocessing Market

16. UK Single Use Bioprocessing Market

17. Germany Single Use Bioprocessing Market

18. France Single Use Bioprocessing Market

19. Italy Single Use Bioprocessing Market

20. Spain Single Use Bioprocessing Market

21. Eastern Europe Single Use Bioprocessing Market

22. Russia Single Use Bioprocessing Market

23. North America Single Use Bioprocessing Market

24. USA Single Use Bioprocessing Market

25. Canada Single Use Bioprocessing Market

26. South America Single Use Bioprocessing Market

27. Brazil Single Use Bioprocessing Market

28. Middle East Single Use Bioprocessing Market

29. Africa Single Use Bioprocessing Market

30. Single Use Bioprocessing Market Competitive Landscape And Company Profiles

31. Single Use Bioprocessing Market Other Major And Innovative Companies

32. Global Single Use Bioprocessing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Single Use Bioprocessing Market

34. Recent Developments In The Single Use Bioprocessing Market

35. Single Use Bioprocessing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기